Respiratory syncytial virus vaccines for toddlers and school-aged children: a pressing necessity for global health.
作者信息
Sheng Jie, Tao Keyu, Zhang Chao, Zhang Aiping, Li Yang, Ji Jianjian
机构信息
Jiangsu Key Laboratory of Pediatric Respiratory Disease, Jiangsu Provincial Research Institute of Chinese Medicine Schools, Nanjing University of Chinese Medicine, Nanjing, China.
Clinical Laboratory, Jiangning District Center for Disease Control and Prevention, Nanjing, China.
出版信息
Front Pediatr. 2025 Sep 1;13:1607236. doi: 10.3389/fped.2025.1607236. eCollection 2025.
Abstract
摘要
相似文献
1
Respiratory syncytial virus vaccines for toddlers and school-aged children: a pressing necessity for global health.针对幼儿和学龄儿童的呼吸道合胞病毒疫苗：全球健康的迫切需求。
Front Pediatr. 2025 Sep 1;13:1607236. doi: 10.3389/fped.2025.1607236. eCollection 2025.
2
Respiratory syncytial virus (RSV) infections in adults: Current trends and recommendations for prevention - a global challenge from a local perspective.成人呼吸道合胞病毒（RSV）感染：当前趋势及预防建议——从地方视角看全球挑战
Hum Vaccin Immunother. 2025 Dec;21(1):2514357. doi: 10.1080/21645515.2025.2514357. Epub 2025 Jun 18.
3
Public health impact and cost-effectiveness of the adjuvanted RSVPreF3 vaccine for respiratory syncytial virus prevention among adults aged 50 years and older in Germany.德国50岁及以上成年人中用于预防呼吸道合胞病毒的佐剂RSVPreF3疫苗的公共卫生影响和成本效益
Expert Rev Vaccines. 2025 Jul 28. doi: 10.1080/14760584.2025.2539887.
4
Acceptance and preference between respiratory syncytial virus vaccination during pregnancy and infant monoclonal antibody among pregnant and postpartum persons in Canada.加拿大孕妇和产后人群对孕期呼吸道合胞病毒疫苗接种与婴儿单克隆抗体的接受度和偏好。
Vaccine. 2025 Mar 19;50:126818. doi: 10.1016/j.vaccine.2025.126818. Epub 2025 Feb 6.
5
Respiratory syncytial virus (RSV) prevention: Perception and willingness of expectant parents in the Netherlands.呼吸道合胞病毒（RSV）预防：荷兰准父母的认知与意愿
Vaccine. 2025 Jan 12;44:126541. doi: 10.1016/j.vaccine.2024.126541. Epub 2024 Nov 30.
6
Pregnant women's choices for preventing respiratory syncytial virus (RSV).孕妇预防呼吸道合胞病毒（RSV）的选择。
Vaccine. 2025 Feb 27;48:126790. doi: 10.1016/j.vaccine.2025.126790. Epub 2025 Jan 29.
7
Budget impact of maternal vaccination with RSVpreF to protect privately insured infants in Dubai against respiratory syncytial virus.使用呼吸道合胞病毒融合前体蛋白（RSVpreF）对迪拜的私人保险婴儿进行母体疫苗接种以预防呼吸道合胞病毒的预算影响。
Hum Vaccin Immunother. 2025 Dec;21(1):2523106. doi: 10.1080/21645515.2025.2523106. Epub 2025 Jul 2.
8
Impact and cost-effectiveness analyses of vaccination for prevention of respiratory syncytial virus disease among older adults in Ontario: A Canadian Immunization Research Network (CIRN) study.安大略省老年人接种疫苗预防呼吸道合胞病毒病的影响和成本效益分析：加拿大免疫研究网络（CIRN）研究。
Vaccine. 2024 Mar 7;42(7):1768-1776. doi: 10.1016/j.vaccine.2024.02.041. Epub 2024 Feb 16.
9
Stable Attenuation of Human Respiratory Syncytial Virus for Live Vaccines by Deletion and Insertion of Amino Acids in the Hinge Region between the mRNA Capping and Methyltransferase Domains of the Large Polymerase Protein.通过删除和插入大聚合酶蛋白的 mRNA 加帽和甲基转移酶结构域之间的铰链区中的氨基酸，稳定衰减人呼吸道合胞病毒用于活疫苗。
J Virol. 2020 Nov 23;94(24). doi: 10.1128/JVI.01831-20.
10
Awareness of respiratory syncytial virus and other respiratory disease vaccines among healthcare professionals and their patients in Italy: Insights from a literature review and a web-based survey.意大利医疗保健专业人员及其患者对呼吸道合胞病毒和其他呼吸道疾病疫苗的认知：文献综述和网络调查的见解
Hum Vaccin Immunother. 2025 Dec;21(1):2552557. doi: 10.1080/21645515.2025.2552557. Epub 2025 Sep 3.
本文引用的文献
1
180-day efficacy of nirsevimab against hospitalisation for respiratory syncytial virus lower respiratory tract infections in infants (HARMONIE): a randomised, controlled, phase 3b trial.Nirsevimab预防婴儿呼吸道合胞病毒下呼吸道感染住院治疗的180天疗效（HARMONIE）：一项随机对照3b期试验
Lancet Child Adolesc Health. 2025 Jun;9(6):404-412. doi: 10.1016/S2352-4642(25)00102-6.
2
Development, Current Status, and Remaining Challenges for Respiratory Syncytial Virus Vaccines.呼吸道合胞病毒疫苗的研发、现状及尚存挑战
Vaccines (Basel). 2025 Jan 21;13(2):97. doi: 10.3390/vaccines13020097.
3
Genotypic and phenotypic characterisation of respiratory syncytial virus after nirsevimab breakthrough infections: a large, multicentre, observational, real-world study.在接受尼塞韦单抗突破性感染后呼吸道合胞病毒的基因和表型特征：一项大型、多中心、观察性、真实世界研究。
Lancet Infect Dis. 2025 Mar;25(3):301-311. doi: 10.1016/S1473-3099(24)00570-X. Epub 2024 Oct 14.
4
The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global access.呼吸道合胞病毒疫苗和单克隆抗体领域：通向全球可及之路。
Lancet Infect Dis. 2024 Dec;24(12):e747-e761. doi: 10.1016/S1473-3099(24)00455-9. Epub 2024 Sep 23.
5
Functional and epigenetic changes in monocytes from adults immunized with an AS01-adjuvanted vaccine.接种 AS01 佐剂疫苗的成年人单核细胞的功能和表观遗传变化。
Sci Transl Med. 2024 Jul 31;16(758):eadl3381. doi: 10.1126/scitranslmed.adl3381.
6
Passive Immunization Strategies to Prevent Severe Respiratory Syncytial Virus Infection Among Newborns and Young Infants.预防新生儿和婴幼儿严重呼吸道合胞病毒感染的被动免疫策略。
J Pediatric Infect Dis Soc. 2024 Jul 12;13(Supplement_2):S110-S114. doi: 10.1093/jpids/piae058.
7
B cell memory: from generation to reactivation: a multipronged defense wall against pathogens.B细胞记忆：从产生到重新激活——抵御病原体的多层面防御壁垒
Cell Death Discov. 2024 Mar 7;10(1):117. doi: 10.1038/s41420-024-01889-5.
8
Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data.2019 年导致早产儿和幼儿急性下呼吸道感染的呼吸道合胞病毒的全球疾病负担及危险因素：汇总和个体参与者数据的系统评价和荟萃分析。
Lancet. 2024 Mar 30;403(10433):1241-1253. doi: 10.1016/S0140-6736(24)00138-7. Epub 2024 Feb 14.
9
European priority review vouchers for neglected disease product development.欧洲优先审评券，用于治疗被忽视疾病的药物研发。
BMJ Glob Health. 2024 Jan 30;9(1):e013686. doi: 10.1136/bmjgh-2023-013686.
10
Infectious virus shedding duration reflects secretory IgA antibody response latency after SARS-CoV-2 infection.传染性病毒排出持续时间反映了 SARS-CoV-2 感染后分泌型 IgA 抗体应答的潜伏期。
Proc Natl Acad Sci U S A. 2023 Dec 26;120(52):e2314808120. doi: 10.1073/pnas.2314808120. Epub 2023 Dec 22.
Zotero 插件